Marksans Pharma Ltd - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity

Representative image of AI-driven central nervous system drug discovery, reflecting how Insilico Medicine expanded its Tenacia Biotechnology collaboration in a deal worth up to $94.75 million.

Insilico Medicine just doubled down on CNS with Tenacia. Here’s why that matters now.

Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market

NEXT plc (LON: NXT) delivers record profit of £1.16bn as international surge and brand portfolio drive 17% EPS growth

Read More

3 minute read

Pharma Industry News

Marksans Pharma smashes records: 18% revenue surge and massive profit boost in Q1 FY25

Marksans Pharma Ltd. (NSE: MARKSANS; BSE Code: 524404) has unveiled its financial results for the quarter ending June…

byPallavi Madhiraju

August 13, 2024

web analytics